Zoetis Inc. Files 8-K on Material Agreements

Ticker: ZTS · Form: 8-K · Filed: Aug 27, 2025 · CIK: 1555280

Zoetis Inc. 8-K Filing Summary
FieldDetail
CompanyZoetis Inc. (ZTS)
Form Type8-K
Filed DateAug 27, 2025
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$0.01, $1.25 billion, $1.75 billion
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, financial-obligation

TL;DR

Zoetis 8-K: New deals in, old deals out, money obligations created. Details TBD.

AI Summary

On August 27, 2025, Zoetis Inc. filed an 8-K report indicating the entry into and termination of material definitive agreements, as well as the creation of direct financial obligations. The filing does not specify the parties involved in these agreements or the financial details of the obligations.

Why It Matters

This filing signals significant corporate actions, including potential new financial commitments and the dissolution of existing ones, which could impact Zoetis's financial structure and strategic direction.

Risk Assessment

Risk Level: medium — The filing indicates material definitive agreements were entered into and terminated, and financial obligations were created, suggesting significant, though unspecified, corporate activity.

Key Players & Entities

  • Zoetis Inc. (company) — Registrant
  • August 27, 2025 (date) — Date of report

FAQ

What specific material definitive agreements were entered into by Zoetis Inc. on or around August 27, 2025?

The filing does not specify the details of the material definitive agreements entered into.

Which material definitive agreements were terminated by Zoetis Inc. on or around August 27, 2025?

The filing does not specify the details of the material definitive agreements that were terminated.

What are the details of the direct financial obligations or off-balance sheet arrangements created by Zoetis Inc. as reported in this 8-K?

The filing states that a direct financial obligation or an obligation under an off-balance sheet arrangement was created, but does not provide specific details.

What is the nature of the "Item Information" listed in the 8-K filing for Zoetis Inc.?

The Item Information includes 'Entry into a Material Definitive Agreement', 'Termination of a Material Definitive Agreement', and 'Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant'.

What is Zoetis Inc.'s principal executive office address and phone number as listed in the filing?

Zoetis Inc.'s principal executive offices are located at 10 Sylvan Way, Parsippany, New Jersey, 07054, and the telephone number is (973) 822-7000.

Filing Stats: 905 words · 4 min read · ~3 pages · Grade level 10.7 · Accepted 2025-08-27 16:21:54

Key Financial Figures

  • $0.01 — ich registered Common Stock, par value $0.01 per share ZTS New York Stock Exchan
  • $1.25 billion — ation agents, providing for a five-year $1.25 billion senior unsecured revolving credit facil
  • $1.75 billion — nts under the Credit Agreement to up to $1.75 billion. The Credit Agreement is not guaranteed

Filing Documents

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 27, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 10 Sylvan Way , Parsippany , New Jersey 07054 (Address of principal executive offices) (Zip Code) (973) 822-7000 (Registrant's telephone number, including area code) Not Applicable (Former Name or Former Address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share ZTS New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item1.01. Entry into a Material Definitive Agreement. Revolving Credit Facility On August 27, 2025, Zoetis Inc. (the "Company") entered into a revolving credit agreement (the "Credit Agreement") with a syndicate of banks, JPMorgan Chase Bank, N.A., as administrative agent, and Barclays Bank PLC, Bank of America, N.A., Citibank, N.A. and MUFG Bank, Ltd., as syndication agents, providing for a five-year $1.25 billion senior unsecured revolving credit facility. The Credit Agreement replaced the Company's existing revolving credit facility. Subject to certain conditions, the Company will have the right to increase the commitments under the Credit Agreement to up to $1.75 billion. The Credit Agreement is not guaranteed by the Company's subsidiaries. Loans under the Credit Agreement will bear interest, at the Company's option, at rates equal to either: (a) a base rate or (b) a term SOFR rate, in each case plus an applicable margin. Additionally, the Company will pay a facility fee on the commitments under the Credit Agreement, regardless of whether borrowings are outstanding under the Credit Agreement. The applicable margins and the facility fee are determined based on the public ratings of the Company's senior unsecured non-credit enhanced long-term debt. Interest on borrowings and the facility fee are generally payable quarterly in arrears; however, for loans bearing interest based on a term SOFR rate with a term shorter than three months, interest is payable at the end of such term. The Company may voluntarily prepay loans and/or reduce the commitment under the Credit Agreement, in whole or in part, without penalty or premium, subject to certain minimum amounts and increments and the payment of customary breakage costs. No mandatory prepayment is required under the Credit Agreement. The Credit Agreement contains a financial covenant requiring the Company to not exceed a maximum total leverage ratio. In addition, the Credit Agreement contains customary affirmative and negative covenants that, among other things, limit or restrict the Company's and its subsidiaries' ability, subject to certain exceptions, to incur liens, merge, consolidate or sell, transfer or lease assets and incur priority indebtedness. The Credit Agreement also contains customary events of default. The description of the Credit Agreement contained herein is not intended to be complete and is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. Item1.02. Termination of a Material Definitive Agreement. On August 27, 2025, the Company terminated that certain credit agreement dated as of December 21, 2022, among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, (the "Prior Credit Agreement") and all commitments to extend further credi

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.